{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T10:49:41Z","timestamp":1783680581392,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T00:00:00Z","timestamp":1620000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T00:00:00Z","timestamp":1620000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DMR-1827745"],"award-info":[{"award-number":["DMR-1827745"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"U.S. Department of Health & Human Services | NIH | NIH Office of the Director","doi-asserted-by":"publisher","award":["U24 CA224370"],"award-info":[{"award-number":["U24 CA224370"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Mach Intell"],"DOI":"10.1038\/s42256-021-00335-w","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T12:03:40Z","timestamp":1620043420000},"page":"527-535","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["A machine learning platform to estimate anti-SARS-CoV-2 activities"],"prefix":"10.1038","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0417-3120","authenticated-orcid":false,"given":"Govinda B.","family":"KC","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9361-8437","authenticated-orcid":false,"given":"Giovanni","family":"Bocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srijan","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4782-3736","authenticated-orcid":false,"given":"Md Mahmudulla","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayme","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy J.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4665-6665","authenticated-orcid":false,"given":"Suman","family":"Sirimulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6195-6976","authenticated-orcid":false,"given":"Tudor I.","family":"Oprea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,3]]},"reference":[{"key":"335_CR1","doi-asserted-by":"publisher","unstructured":"Gorshkov, K., Chen, Z.C., Bostwick, R. et al. The SARS-CoV-2 cytopathic effect is blocked by lysosome alkalizing small molecules. ACS Infect. Dis. https:\/\/doi.org\/10.1021\/acsinfecdis.0c00349 (2021).","DOI":"10.1021\/acsinfecdis.0c00349"},{"key":"335_CR2","doi-asserted-by":"publisher","first-page":"115422","DOI":"10.1016\/j.bmc.2020.115422","volume":"28","author":"H Sun","year":"2020","unstructured":"Sun, H., Wang, Y., Cheff, D. M., Hall, M. D. & Shen, M. Predictive models for estimating cytotoxicity on the basis of chemical structures. Bioorg. Med. Chem. 28, 115422 (2020).","journal-title":"Bioorg. Med. Chem."},{"key":"335_CR3","doi-asserted-by":"crossref","unstructured":"Hanson, Q. M. et al. Targeting ACE2\u2013RBD interaction as a platform for COVID-19 therapeutics: development and drug-repurposing screen of an AlphaLISA proximity assay. ACS Pharmacol. Transl. Sci. 6, 1352\u20131360 (2020).","DOI":"10.1021\/acsptsci.0c00161"},{"key":"335_CR4","doi-asserted-by":"crossref","unstructured":"Brimacombe, K. R. et al. An OpenData portal to share COVID-19 drug repurposing data in real time. Preprint at https:\/\/www.biorxiv.org\/content\/10.1101\/2020.06.04.135046v1 (2020).","DOI":"10.1101\/2020.06.04.135046"},{"key":"335_CR5","unstructured":"SARS-CoV-2 Assays (NCATS, accessed 25 September 2020); https:\/\/opendata.ncats.nih.gov\/covid19\/assays"},{"key":"335_CR6","doi-asserted-by":"publisher","unstructured":"Huang, R., Xu, M., Zhu, H. et al. Biological activity-based modeling identifies antiviral leads against SARS-CoV-2. Nat. Biotechnol. https:\/\/doi.org\/10.1038\/s41587-021-00839-1 (2021).","DOI":"10.1038\/s41587-021-00839-1"},{"key":"335_CR7","doi-asserted-by":"publisher","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","volume":"44","author":"S Kim","year":"2016","unstructured":"Kim, S. et al. PubChem substance and compound databases. Nucl. Acids Res. 44, D1202\u2013D1213 (2016).","journal-title":"Nucl. Acids Res."},{"key":"335_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1021\/ci00057a005","volume":"28","author":"D Weininger","year":"1988","unstructured":"Weininger, D. SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. J. Chem. Inf. Comput. Sci. 28, 31\u201336 (1988).","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"335_CR9","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/minf.201100023","volume":"30","author":"TI Oprea","year":"2011","unstructured":"Oprea, T. I. et al. Associating drugs, targets and clinical outcomes into an integrated network affords a new platform for computer-aided drug repurposing. Mol. Inform. 30, 100\u2013111 (2011).","journal-title":"Mol. Inform."},{"key":"335_CR10","doi-asserted-by":"crossref","unstructured":"Berthold Michael, R. et al. in Data Analysis, Machine Learning and Applications 319\u2013326 (Springer, 2007).","DOI":"10.1007\/978-3-540-78246-9_38"},{"key":"335_CR11","doi-asserted-by":"publisher","first-page":"D932","DOI":"10.1093\/nar\/gkw993","volume":"45","author":"O Ursu","year":"2017","unstructured":"Ursu, O. et al. DrugCentral: online drug compendium. Nucl. Acids Res. 45, D932\u2013D939 (2017).","journal-title":"Nucl. Acids Res."},{"key":"335_CR12","doi-asserted-by":"publisher","first-page":"D963","DOI":"10.1093\/nar\/gky963","volume":"47","author":"O Ursu","year":"2019","unstructured":"Ursu, O. et al. DrugCentral 2018: an update. Nucl. Acids Res. 47, D963\u2013D970 (2019).","journal-title":"Nucl. Acids Res."},{"key":"335_CR13","doi-asserted-by":"crossref","unstructured":"Avram, S. et al. DrugCentral 2021 supports drug discovery and repositioning. Nucl. Acids Res. 49, D1160\u2013D1169 (2020).","DOI":"10.1093\/nar\/gkaa997"},{"key":"335_CR14","unstructured":"Markossian, S. et al. (eds) Assay Guidance Manual (Eli Lilly & Company and the National Center for Advancing Translational Sciences, 2004)."},{"key":"335_CR15","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa, F. et al. Scikit-learn: machine learning in Python. J. Mach. Learning Res. 12, 2825\u20132830 (2011).","journal-title":"J. Mach. Learning Res."},{"key":"335_CR16","doi-asserted-by":"crossref","unstructured":"Oprea, T. I. & Waller, C. L. in Reviews in Computational Chemistry Vol. 11, 127\u2013182 (John Wiley and Sons, 2007).","DOI":"10.1002\/9780470125885.ch3"},{"key":"335_CR17","unstructured":"hypopt (Github, accessed 24 July 2020); https:\/\/github.com\/cgnorthcutt\/hypopt"},{"key":"335_CR18","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1289\/ehp.5758","volume":"111","author":"L Eriksson","year":"2003","unstructured":"Eriksson, L. et al. Methods for reliability and uncertainty assessment and for applicability evaluations of classification- and regression-based QSARs. Environ. Health Perspect. 111, 1361\u20131375 (2003).","journal-title":"Environ. Health Perspect."},{"key":"335_CR19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1021\/acs.jcim.8b00597","volume":"59","author":"R Liu","year":"2019","unstructured":"Liu, R. & Wallqvist, A. Molecular similarity-based domain applicability metric efficiently identifies out-of-domain compounds. J. Chem. Inf. Model. 59, 181\u2013189 (2019).","journal-title":"J. Chem. Inf. Model."},{"key":"335_CR20","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/minf.201501019","volume":"35","author":"M Mathea","year":"2016","unstructured":"Mathea, M., Klingspohn, W. & Baumann, K. Chemoinformatic classification methods and their applicability domain. Mol. Inform. 35, 160\u2013180 (2016).","journal-title":"Mol. Inform."},{"key":"335_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1021\/ci00062a008","volume":"29","author":"D Weininger","year":"1989","unstructured":"Weininger, D., Weininger, A. & Weininger, J. L. SMILES. 2. Algorithm for generation of unique SMILES notation. J. Chem. Inf. Comput. Sci. 29, 97\u2013101 (1989).","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"335_CR22","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1126\/science.132.3434.1115","volume":"132","author":"DJ Rogers","year":"1960","unstructured":"Rogers, D. J. & Tanimoto, T. T. A computer program for classifying plants. Science 132, 1115\u20131118 (1960).","journal-title":"Science"},{"key":"335_CR23","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1021\/ci049867x","volume":"44","author":"M Whittle","year":"2004","unstructured":"Whittle, M., Gillet, V. J., Willett, P., Alex, A. & Loesel, J. Enhancing the effectiveness of virtual screening by fusing nearest neighbor lists: a comparison of similarity coefficients. J. Chem. Inf. Comput. Sci. 44, 1840\u20131848 (2004).","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"335_CR24","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1021\/ac60361a037","volume":"47","author":"RN Carey","year":"1975","unstructured":"Carey, R. N., Wold, S. & Westgard, J. O. Principal component analysis. Alternative to referee methods in method comparison studies. Anal. Chem. 47, 1824\u20131829 (1975).","journal-title":"Anal. Chem."},{"key":"335_CR25","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1016\/S0928-0987(00)00162-7","volume":"11","author":"G Cruciani","year":"2000","unstructured":"Cruciani, G., Pastor, M. & Guba, W. VolSurf: a new tool for the pharmacokinetic optimization of lead compounds. Eur. J. Pharm. Sci. 11, S29\u2013S39 (2000).","journal-title":"Eur. J. Pharm. Sci."},{"key":"335_CR26","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s10822-005-8694-y","volume":"19","author":"IV Tetko","year":"2005","unstructured":"Tetko, I. V. et al. Virtual computational chemistry laboratory\u2014design and description. J. Comput. Aided Mol. Des. 19, 453\u2013463 (2005).","journal-title":"J. Comput. Aided Mol. Des."},{"key":"335_CR27","doi-asserted-by":"publisher","first-page":"100090","DOI":"10.1016\/j.patter.2020.100090","volume":"1","author":"MV Kuleshov","year":"2020","unstructured":"Kuleshov, M. V. et al. The COVID-19 drug and gene set library. Patterns 1, 100090 (2020).","journal-title":"Patterns"},{"key":"335_CR28","doi-asserted-by":"publisher","first-page":"e00819-20","DOI":"10.1128\/AAC.00819-20","volume":"64","author":"S Jeon","year":"2020","unstructured":"Jeon, S. et al. Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs. Antimicrob. Agents Chemother. 64, e00819-20 (2020).","journal-title":"Antimicrob. Agents Chemother."},{"key":"335_CR29","doi-asserted-by":"publisher","first-page":"e01218-20","DOI":"10.1128\/JVI.01218-20","volume":"94","author":"S Weston","year":"2020","unstructured":"Weston, S. et al. Broad anti-coronavirus activity of Food and Drug Administration-approved drugs against SARS-CoV-2 in vitro and SARS-CoV in vivo. J. Virol. 94, e01218-20 (2020).","journal-title":"J. Virol."},{"key":"335_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-70143-6","volume":"10","author":"F Touret","year":"2020","unstructured":"Touret, F. et al. In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication. Sci. Rep. 10, 13093 (2020).","journal-title":"Sci. Rep."},{"key":"335_CR31","unstructured":"Xing, J. et al. Reversal of infected host gene expression identifies repurposed drug candidates for COVID-19. Preprint at https:\/\/www.biorxiv.org\/content\/10.1101\/2020.04.07.030734v1 (2020)."},{"key":"335_CR32","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41586-020-2577-1","volume":"586","author":"L Riva","year":"2020","unstructured":"Riva, L. et al. Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing. Nature 586, 113\u2013119 (2020).","journal-title":"Nature"},{"key":"335_CR33","doi-asserted-by":"publisher","first-page":"104786","DOI":"10.1016\/j.antiviral.2020.104786","volume":"178","author":"K-T Choy","year":"2020","unstructured":"Choy, K.-T. et al. Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro. Antiviral Res. 178, 104786 (2020).","journal-title":"Antiviral Res."},{"key":"335_CR34","unstructured":"Mirabelli, C. et al. Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19. Preprint at https:\/\/www.biorxiv.org\/content\/10.1101\/2020.05.27.117184v4 (2020)."},{"key":"335_CR35","doi-asserted-by":"crossref","unstructured":"Riva, L. et al. Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing. Nature 586, 113\u2013119 (2020).","DOI":"10.1038\/s41586-020-2577-1"},{"key":"335_CR36","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","volume":"582","author":"Z Jin","year":"2020","unstructured":"Jin, Z. et al. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature 582, 289\u2013293 (2020).","journal-title":"Nature"},{"key":"335_CR37","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41597-021-00848-4","volume":"8","author":"B Ellinger","year":"2021","unstructured":"Ellinger, B. et al. A SARS-CoV-2 cytopathicity dataset generated by high-content screening of a large drug repurposing collection. Sci. Data 8, 70 (2021).","journal-title":"Sci. Data"},{"key":"335_CR38","doi-asserted-by":"crossref","unstructured":"Shrimp, J. H. et al. An enzymatic TMPRSS2 assay for assessment of clinical candidates and discovery of inhibitors as potential treatment of COVID-19. ACS Pharmacol. Transl. Sci. 5, 997\u20131007 (2020).","DOI":"10.1021\/acsptsci.0c00106"},{"key":"335_CR39","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271\u2013280.e8 (2020).","journal-title":"Cell"},{"key":"335_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.virol.2017.12.015","volume":"517","author":"JK Millet","year":"2018","unstructured":"Millet, J. K. & Whittaker, G. R. Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells. Virology 517, 3\u20138 (2018).","journal-title":"Virology"},{"key":"335_CR41","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.cardiores.2006.09.006","volume":"73","author":"S Keidar","year":"2007","unstructured":"Keidar, S., Kaplan, M. & Gamliel-Lazarovich, A. ACE2 of the heart: from angiotensin I to angiotensin (1\u20137). Cardiovasc. Res. 73, 463\u2013469 (2007).","journal-title":"Cardiovasc. Res."},{"key":"335_CR42","doi-asserted-by":"publisher","first-page":"6595","DOI":"10.1021\/acs.jmedchem.5b01461","volume":"59","author":"T Pillaiyar","year":"2016","unstructured":"Pillaiyar, T., Manickam, M., Namasivayam, V., Hayashi, Y. & Jung, S.-H. An overview of severe acute respiratory syndrome\u2013coronavirus (SARS-CoV) 3CL protease inhibitors: peptidomimetics and small molecule chemotherapy. J. Med. Chem. 59, 6595\u20136628 (2016).","journal-title":"J. Med. Chem."},{"key":"335_CR43","doi-asserted-by":"publisher","unstructured":"Millet, J. K. et al. Production of pseudotyped particles to study highly pathogenic coronaviruses in a biosafety level 2 setting. J. Vis. Exp. https:\/\/doi.org\/10.3791\/59010 (2019).","DOI":"10.3791\/59010"},{"key":"335_CR44","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13321-015-0068-4","volume":"7","author":"SR Heller","year":"2015","unstructured":"Heller, S. R., McNaught, A., Pletnev, I., Stein, S. & Tchekhovskoi, D. InChI, the IUPAC international chemical identifier. J. Cheminform. 7, 23 (2015).","journal-title":"J. Cheminform."},{"key":"335_CR45","unstructured":"Landrum, G. et al. RDKit: Open-source Cheminformatics Software (RDKit, accessed 10 May 2020); https:\/\/www.rdkit.org\/"},{"key":"335_CR46","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1758-2946-5-26","volume":"5","author":"S Riniker","year":"2013","unstructured":"Riniker, S. & Landrum, G. A. Open-source platform to benchmark fingerprints for ligand-based virtual screening. J. Cheminform. 5, 26 (2013).","journal-title":"J. Cheminform."},{"key":"335_CR47","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1021\/ci100050t","volume":"50","author":"D Rogers","year":"2010","unstructured":"Rogers, D. & Hahn, M. Extended-connectivity fingerprints. J. Chem. Inf. Model. 50, 742\u2013754 (2010).","journal-title":"J. Chem. Inf. Model."},{"key":"335_CR48","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1021\/acs.jcim.6b00505","volume":"56","author":"M Sud","year":"2016","unstructured":"Sud, M. MayaChemTools: an open source package for computational drug discovery. J. Chem. Inf. Model. 56, 2292\u20132297 (2016).","journal-title":"J. Chem. Inf. Model."},{"key":"335_CR49","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1021\/ci6002416","volume":"46","author":"F Bonach\u00e9ra","year":"2006","unstructured":"Bonach\u00e9ra, F., Parent, B., Barbosa, F., Froloff, N. & Horvath, D. Fuzzy tricentric pharmacophore fingerprints. 1. Topological fuzzy pharmacophore triplets and adapted molecular similarity scoring schemes. J. Chem. Inf. Model. 46, 2457\u20132477 (2006).","journal-title":"J. Chem. Inf. Model."},{"key":"335_CR50","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1021\/jm00145a002","volume":"28","author":"PJ Goodford","year":"1985","unstructured":"Goodford, P. J. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J. Med. Chem. 28, 849\u2013857 (1985).","journal-title":"J. Med. Chem."},{"key":"335_CR51","doi-asserted-by":"crossref","unstructured":"Zamora, I., Oprea, T., Cruciani, G., Pastor, M. & Ungell, A.-L. Surface descriptors for protein\u2013ligand affinity prediction. J. Med. Chem. 46, 25\u201333 (2003).","DOI":"10.1021\/jm011051p"}],"container-title":["Nature Machine Intelligence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42256-021-00335-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42256-021-00335-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42256-021-00335-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T15:51:41Z","timestamp":1670082701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42256-021-00335-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,3]]},"references-count":51,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["335"],"URL":"https:\/\/doi.org\/10.1038\/s42256-021-00335-w","relation":{"has-review":[{"id-type":"doi","id":"10.32388\/NE9JIR","asserted-by":"object"},{"id-type":"doi","id":"10.32388\/TKJA94","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.26434\/chemrxiv.12915779.v3","asserted-by":"object"}]},"ISSN":["2522-5839"],"issn-type":[{"value":"2522-5839","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,3]]},"assertion":[{"value":"12 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.I.O. has received honoraria from or consulted for Abbott, AstraZeneca, Chiron, Genentech, Infinity Pharmaceuticals, Merz Pharmaceuticals, Merck Darmstadt, Mitsubishi Tanabe, Novartis, Ono Pharmaceuticals, Pfizer, Roche, Sanofi and Wyeth, and is on the Scientific Advisory Board of ChemDiv and InSilico Medicine.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}